Rockwell Medical Technologies (RMTI) Reports In-Line Q2 Revenue

Rockwell Medical Technologies (NASDAQ: RMTI) reported Q2 EPS of ($0.24), may not compare to the analyst estimate of ($0.13). Revenue for the quarter came in at $14.9 million versus the consensus estimate of $14.9 million.

For earnings history and earnings-related data on Rockwell Medical Technologies (RMTI) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Barclays says AI trade is maturing, favors greater diversification
• UBS cuts KOSPI target by nearly 10% to reflect higher rates